Event | January – February 2022
With the annual J.P. Morgan Healthcare Conference pivoting to a virtual format again in 2022, we will be hosting a lineup of virtual events and reports aligned with the industry’s biggest conference.
Complimentary Virtual Meeting with our Global Team
Connect with Baker McKenzie’s life sciences and healthcare lawyers around the world! Partake in a complimentary virtual meeting covering a range of areas of law to help grow and expand your business internationally. Contact your Baker McKenzie contact or Grace Gato to arrange a meeting. Please indicate your business need, geographies of interest and any other relevant information.
Funding Growth and the Future of Life Sciences
How do life sciences companies intend to leverage new and existing sources of growth? Explore the trajectory of life sciences transactions in our latest report that focuses on:
- The enduring robust appetite for M&A, carve-outs, divestitures, partnerships, licensing and collaboration agreements
- The rising focus on sustainability goals aligned with pursuing deals linked to corporate power purchase agreements (PPAs) and green financing
- Continued VC investment and increasing appetitive from private equity sponsors in pre-revenue stages
- Regional divergences and subsector trends
Click here to access the report.
Spotlight on Asia Pacific: DealSCAPE
This report explores the defining characteristics of pharmaceutical and biotech transactions in 2022 and recommends a framework to understand the legal complexity in a fast-evolving sector and at a uniquely opportunistic time. As you identify key opportunities to transform your business responsibly and strategically, our new report will help you navigate legal complexity and stress test plans in an evolving transactional landscape.
Virtual Events: January – February 2022
To register, please click on the relevant links or reach out to the contacts listed.
|Import and Export of Cannabis: What You Need To Know|
January 20 | 2:00 pm GMT | CLE/CPD eligible in certain jurisdictions
|A panel of trade compliance experts will discuss topics such how the cannabis industry can be more trade compliant, how to navigate the multi-jurisdictional variances in customs laws, how to reduce the risks associated with the import and export of cannabis and how to identify and mitigate sanctions risks. We will also showcase our interactive global dashboard, which provides an overview of import and export rules in over 100 markets.|
|Future of Disputes: Healthcare and Life Sciences|
February 16 | 3:00 pm GMT
|As a result of COVID-19, healthcare and life sciences is not only the fastest growing industry in the world but it is very much in the spotlight. Interact with a case study to explore compliance, litigation and enforcement risks resulting from the evolving landscape.|
|The ESG Imperative: Rethinking Healthcare & Life Sciences Supply Chains|
February 23 | 2:00 pm GMT | CLE/CPD eligible in certain jurisdictions
|Beyond resilience, the supply chains of the future are expected to be sustainable, embracing ESG principles. For the healthcare and life sciences sector, this means integrating corporate governance and inclusion & diversity into the value chain. It also means looking at access to medicines and medical devices from an ESG perspective and exploring alternatives such as corporate power purchase agreements. Our panel of experts will discuss how these trends are set to advance and transform the healthcare and life sciences supply chain in 2022 and beyond.|